Balchem Corporation (FRA:BL9B)

Germany flag Germany · Delayed Price · Currency is EUR
141.20
-3.20 (-2.22%)
Last updated: Feb 20, 2026, 3:49 PM CET
Market Cap4.71B -8.4%
Revenue (ttm)883.35M +8.8%
Net Income131.88M +20.5%
EPS4.05 +20.9%
Shares Outn/a
PE Ratio35.71
Forward PE30.45
Dividend0.82 (0.55%)
Ex-Dividend DateDec 23, 2025
Volumen/a
Average Volume3
Open147.10
Previous Close144.40
Day's Range141.20 - 147.10
52-Week Range118.60 - 167.20
Betan/a
RSI49.12
Earnings DateFeb 20, 2026

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipi... [Read more]

Industry Industrial Organic Chemicals
Founded 1967
Employees 1,355
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol BL9B
Full Company Profile

Financial Performance

In 2025, Balchem's revenue was $1.04 billion, an increase of 8.75% compared to the previous year's $953.68 million. Earnings were $154.85 million, an increase of 20.53%.

Financial numbers in USD Financial Statements